We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-21.52%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$82.4M
AUM Growth
-$25.7M
Cap. Flow
-$1.74M
Cap. Flow %
-2.11%
Top 10 Hldgs %
93.72%
Holding
33
New
4
Increased
11
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
KALA icon
KALA BIO
KALA
+$9.07M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.78M
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$1.51M
4
ICMB icon
Investcorp Credit Management BDC
ICMB
+$1.04M
5
GARS
Garrison Capital Inc.
GARS
+$798K

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$1.03M
2
UHAL icon
U-Haul Holding Co
UHAL
+$963K
3
JBGS
JBG SMITH
JBGS
+$707K
4
LITS
Lite Strategy Inc
LITS
+$677K
5
CPRX
Catalyst Pharmaceutical
CPRX
+$276K

Sector Composition

Rank Sector Weight
1 Healthcare 68.7%
2 Financials 10.95%
3 Real Estate 0.94%
4 Technology 0.32%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$29.6M 35.89%
6,604,065
+309,276
+5% +$1.51M
LITS
2
Lite Strategy Inc
LITS
$33M
$9.13M 11.08%
172,956
-10,974
-6% -$677K
GARS
3
DELISTED
Garrison Capital Inc.
GARS
$7.83M 9.5%
1,217,722
+105,205
+9% +$798K
KALA icon
4
KALA BIO
KALA
$15.7M
$6.64M 8.05%
544
+523
+2,490% +$9.07M
MTEM
5
DELISTED
Molecular Templates, Inc.
MTEM
$6.56M 7.96%
108,283
+1,667
+2% +$116K
ICMB icon
6
Investcorp Credit Management BDC
ICMB
$12.4M
$6.43M 7.8%
1,035,553
+134,114
+15% +$1.04M
AMLP icon
7
Alerian MLP ETF
AMLP
$12.7B
$3.6M 4.36%
82,375
-1,308
-2% -$64.2K
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$3.5M 4.25%
+14,010
New +$3.78M
SCYX icon
9
SCYNEXIS
SCYX
$44.5M
$2.08M 2.53%
54,063
– –
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.9M 2.31%
9,312
– –
JBGS
11
JBG SMITH
JBGS
$877M
$778K 0.94%
22,349
-18,821
-46% -$707K
ABDC
12
DELISTED
Alcentra Capital Corp
ABDC
$487K 0.59%
75,303
+17,626
+31% +$110K
KURA icon
13
Kura Oncology
KURA
$967M
$461K 0.56%
32,828
-1,880
-5% -$24.9K
ACRS icon
14
Aclaris Therapeutics
ACRS
$749M
$453K 0.55%
61,264
+21,509
+54% +$222K
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$444K 0.54%
1,457
+607
+71% +$196K
FSK icon
16
FS KKR Capital
FSK
$3.11B
$421K 0.51%
+20,337
New +$506K
ARQL
17
DELISTED
Arqule Inc
ARQL
$345K 0.42%
124,435
+34,181
+38% +$130K
INDP icon
18
Indaptus Therapeutics
INDP
$337M
$318K 0.39%
19
-10
-34% -$136K
MRKR icon
19
Marker Therapeutics
MRKR
$22.3M
$296K 0.36%
5,333
-2,821
-35% -$206K
ARCC icon
20
Ares Capital
ARCC
$13.8B
$273K 0.33%
+17,553
New +$290K
GB
21
DELISTED
Global Blue Group Holding
GB
$262K 0.32%
+27,116
New +$262K
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$219K 0.27%
5,259
+12
+0.2% +$540
MRNS
23
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$176K 0.21%
15,361
+10,316
+204% +$209K
DRNA
24
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$149K 0.18%
13,948
-776
-5% -$10.2K
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$91K 0.11%
123,941
-73,518
-37% -$121K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2018 Portfolio in Review

As of Q4 2018, Caxton Corporation held 33 positions worth $82.4M, down 24% from $108M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Caxton Corporation's Q4 2018 filing shows 4 new, 11 increased, 8 reduced and 8 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,010 shares worth $3.5M. The largest sale was PG&E, an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 60% a quarter earlier, followed by Financials and Real Estate.

  • Caxton Corporation's largest Q4 2018 buy was State Street SPDR S&P 500 ETF Trust: 14,010 shares worth $3.5M.
  • Caxton Corporation added most to KALA BIO in Q4 2018, an estimated $9.07M increase.
  • Caxton Corporation's biggest Q4 2018 reduction was JBG SMITH, cutting an estimated $707K.
  • Caxton Corporation fully exited PG&E in Q4 2018, selling an estimated $1.03M.
  • Caxton Corporation's ten largest holdings make up 94% of its $82.4M portfolio in Q4 2018.
  • Caxton Corporation opened 4 new positions and closed 8 in Q4 2018.
  • Caxton Corporation's portfolio value fell 24% quarter-over-quarter to $82.4M.

Based on Caxton Corporation's 13F filing for Q4 2018, filed 14 Feb 2019.